Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Subcommittee approves bill allowing TennCare to use biosimilars to lower drug costs
Summary
House Bill 1198 passed the Insurance Subcommittee; the bill authorizes TennCare to utilize biosimilars and asks the TennCare Pharmacy Advisory Committee to consider biosimilars on preferred drug lists. Sandoz representative said wider biosimilar use could save Tennessee hundreds of millions annually.
The Insurance Subcommittee voted 6-0 to pass House Bill 1198, which authorizes TennCare to use biosimilars as a cost-saving measure and directs the TennCare Pharmacy Advisory Committee to consider biosimilars when recommending drugs for a state preferred drug list.
"A biosimilar is a biologic product that is highly similar to its reference product... Biosimilars have no…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
